CHC

  • About Us
  • News
  • Coming Up
  • Resources
  • Contact Us
  • Search

Study: The Prohibition of Commercial Support Is Not Needed

April 13, 2010

From Tom Sullivan’s Policy and Medicine blog:

free sms spy app

A study by the Cleveland Clinic’s Center for Continuing Education showed that there was no correlation between the perception of bias and the commercial support status of an activity such as continuing medical education.

Read more on their website.

Comments are welcome here.flagyl generic walmart

Posted in Legislative, Regulatory/FDA

Post navigation

AMA's CME Fact Sheet: On- and Off-Label Use of Prescription Meds
Roundup of Education and Marketing Issues in Light of Health Reform Passage

Categories

  • CHC News
  • Courts/First Amendment
  • Data Privacy
  • Drug Pricing
  • DTC Advertising
  • General
  • Legislative
  • Off-label Promotion
  • Point of Care
  • Regulatory/FDA
  • Uncategorized
  • Washington Focus

Recent Posts

  • Could Burr’s New User Fee Bill Lead to Timely Passage of Legislation?
  • FDA Proposes Increased Consumer Access to Nonprescription Drugs, with Conditions
  • OPDP: Risk, Efficacy Claims for Cholesterol Drug in Doctor Promotion Are False/Misleading
  • HHS Formally Withdraws SUNSET Final Rule
  • OPDP Reorg, Outreach Efforts Designed to Improve Relationship with Industry

Tags

ad tax Advertising Coalition CDER CMS coalition for healthcare communication conflict of interest Congress COVID-19 data privacy DDMAC drug prices in DTC ads drug pricing DTC DTC advertising DTC advertising FDA FDA Commissioner FDA Draft Guidance FDA enforcement FDA social media free speech gifts to physicians HHS John Kamp Jon Bigelow kamp Kate Rawson legislation litigation marketing off-label off-label communication omission of risk OPDP OPDP enforcement PhRMA regulation Risk Information rx data Scott Gottlieb social media sunshine act Untitled Letter Warning Letter Wayne Pines
CHC

Smart Brief
© 2021 Coalition for Healthcare Communication. All rights reserved.